Does Fecal Calprotectin Predict Short-Term Relapse After Stopping Tnfα-Blocking Agents In Inflammatory Bowel Disease Patients In Deep Remission?

Pauliina Molander, Martti Farkkila, Ari Ristimaki, Kimmo Salminen, Helena Kemppainen, Timo Blomster, Ritva Koskela, Airi Jussila, Henna Rautiainen, Markku Nissinen, Johanna Haapamaki, Perttu Arkkila, Urpo Nieminen, Juha Kuisma, Jari Punkkinen, Kaija-Leena Kolho, Harri Mustonen, Taina Sipponen

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalJournal of Crohn's and Colitis
Volume9
Issue number1
Pages (from-to)33-40
Number of pages8
ISSN1873-9946
DOIs
Publication statusPublished - 1 Jan 2015
MoE publication typeA1 Journal article-refereed

Fields of Science

  • Crohn's disease
  • Ulcerative colitis
  • TNF alpha-blocking therapy
  • Histology
  • Fecal biomarkers
  • GRANULOCYTE MARKER PROTEIN
  • EFFICACY END-POINTS
  • CROHNS-DISEASE
  • ULCERATIVE-COLITIS
  • SINGLE-CENTER
  • INTESTINAL INFLAMMATION
  • ACTIVITY INDEXES
  • MEDICAL THERAPY
  • CLINICAL-TRIALS
  • INFLIXIMAB
  • 3121 Internal medicine

Cite this

@article{43c279a881d84487977ebfdd932949f6,
title = "Does Fecal Calprotectin Predict Short-Term Relapse After Stopping Tnfα-Blocking Agents In Inflammatory Bowel Disease Patients In Deep Remission?",
keywords = "Crohn's disease, Ulcerative colitis, TNF alpha-blocking therapy, Histology, Fecal biomarkers, GRANULOCYTE MARKER PROTEIN, EFFICACY END-POINTS, CROHNS-DISEASE, ULCERATIVE-COLITIS, SINGLE-CENTER, INTESTINAL INFLAMMATION, ACTIVITY INDEXES, MEDICAL THERAPY, CLINICAL-TRIALS, INFLIXIMAB, 3121 Internal medicine",
author = "Pauliina Molander and Martti Farkkila and Ari Ristimaki and Kimmo Salminen and Helena Kemppainen and Timo Blomster and Ritva Koskela and Airi Jussila and Henna Rautiainen and Markku Nissinen and Johanna Haapamaki and Perttu Arkkila and Urpo Nieminen and Juha Kuisma and Jari Punkkinen and Kaija-Leena Kolho and Harri Mustonen and Taina Sipponen",
year = "2015",
month = "1",
day = "1",
doi = "10.1016/j.crohns.2014.06.012",
language = "English",
volume = "9",
pages = "33--40",
journal = "Journal of Crohn's and Colitis",
issn = "1873-9946",
publisher = "Oxford University Press",
number = "1",

}

Does Fecal Calprotectin Predict Short-Term Relapse After Stopping Tnfα-Blocking Agents In Inflammatory Bowel Disease Patients In Deep Remission? / Molander, Pauliina; Farkkila, Martti; Ristimaki, Ari; Salminen, Kimmo; Kemppainen, Helena; Blomster, Timo; Koskela, Ritva; Jussila, Airi; Rautiainen, Henna; Nissinen, Markku; Haapamaki, Johanna; Arkkila, Perttu; Nieminen, Urpo; Kuisma, Juha; Punkkinen, Jari; Kolho, Kaija-Leena; Mustonen, Harri; Sipponen, Taina.

In: Journal of Crohn's and Colitis, Vol. 9, No. 1, 01.01.2015, p. 33-40.

Research output: Contribution to journalArticleScientificpeer-review

TY - JOUR

T1 - Does Fecal Calprotectin Predict Short-Term Relapse After Stopping Tnfα-Blocking Agents In Inflammatory Bowel Disease Patients In Deep Remission?

AU - Molander, Pauliina

AU - Farkkila, Martti

AU - Ristimaki, Ari

AU - Salminen, Kimmo

AU - Kemppainen, Helena

AU - Blomster, Timo

AU - Koskela, Ritva

AU - Jussila, Airi

AU - Rautiainen, Henna

AU - Nissinen, Markku

AU - Haapamaki, Johanna

AU - Arkkila, Perttu

AU - Nieminen, Urpo

AU - Kuisma, Juha

AU - Punkkinen, Jari

AU - Kolho, Kaija-Leena

AU - Mustonen, Harri

AU - Sipponen, Taina

PY - 2015/1/1

Y1 - 2015/1/1

KW - Crohn's disease

KW - Ulcerative colitis

KW - TNF alpha-blocking therapy

KW - Histology

KW - Fecal biomarkers

KW - GRANULOCYTE MARKER PROTEIN

KW - EFFICACY END-POINTS

KW - CROHNS-DISEASE

KW - ULCERATIVE-COLITIS

KW - SINGLE-CENTER

KW - INTESTINAL INFLAMMATION

KW - ACTIVITY INDEXES

KW - MEDICAL THERAPY

KW - CLINICAL-TRIALS

KW - INFLIXIMAB

KW - 3121 Internal medicine

U2 - 10.1016/j.crohns.2014.06.012

DO - 10.1016/j.crohns.2014.06.012

M3 - Article

VL - 9

SP - 33

EP - 40

JO - Journal of Crohn's and Colitis

JF - Journal of Crohn's and Colitis

SN - 1873-9946

IS - 1

ER -